Vaccine maker Pfizer paid just $29 million in local tax on its $1.4 billion of sales in Australia during the pandemic, raising political questions about the adequacy of the pharmaceutical giant’s tax payments.
Queensland Liberal National Party senator Gerard Rennick has referred Pfizer’s tax records to federal Treasurer Jim Chalmers and requested the Australian Taxation Office review Pfizer’s transfer pricing arrangements with its global affiliates.
Loading...
John Kehoe is economics editor at Parliament House, Canberra. He writes on economics, politics and business. John was Washington correspondent covering Donald Trump’s first election. He joined the Financial Review in 2008 from Treasury. Connect with John on Twitter. Email John at jkehoe@afr.com
